BUTTERFLY NETWORK INC (BFLY)

US1241551027 - Common Stock

3.37  +0.02 (+0.6%)

After market: 3.37 0 (0%)

Fundamental Rating

3

BFLY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. While BFLY has a great health rating, there are worries on its profitability. BFLY is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

BFLY had negative earnings in the past year.
In the past year BFLY has reported a negative cash flow from operations.
In the past 5 years BFLY always reported negative net income.
In the past 5 years BFLY always reported negative operating cash flow.

1.2 Ratios

BFLY has a Return On Assets of -37.14%. This is comparable to the rest of the industry: BFLY outperforms 40.21% of its industry peers.
BFLY's Return On Equity of -54.18% is in line compared to the rest of the industry. BFLY outperforms 48.15% of its industry peers.
Industry RankSector Rank
ROA -37.14%
ROE -54.18%
ROIC N/A
ROA(3y)-30%
ROA(5y)N/A
ROE(3y)-39.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BFLY has a worse Gross Margin (29.60%) than 75.13% of its industry peers.
BFLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

BFLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BFLY has more shares outstanding
BFLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

BFLY has an Altman-Z score of 0.70. This is a bad value and indicates that BFLY is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.70, BFLY is in line with its industry, outperforming 45.50% of the companies in the same industry.
There is no outstanding debt for BFLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACCN/A
WACC9.43%

2.3 Liquidity

A Current Ratio of 4.66 indicates that BFLY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.66, BFLY is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
A Quick Ratio of 2.95 indicates that BFLY has no problem at all paying its short term obligations.
BFLY's Quick ratio of 2.95 is fine compared to the rest of the industry. BFLY outperforms 64.02% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 2.95

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.59% over the past year.
BFLY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.48%.
EPS 1Y (TTM)24.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.46%
Revenue 1Y (TTM)11.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.33%

3.2 Future

Based on estimates for the next years, BFLY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.99% on average per year.
BFLY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.26% yearly.
EPS Next Y45.6%
EPS Next 2Y21.53%
EPS Next 3Y15.99%
EPS Next 5YN/A
Revenue Next Year24.78%
Revenue Next 2Y21.4%
Revenue Next 3Y20.26%
Revenue Next 5YN/A

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

BFLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BFLY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BFLY's earnings are expected to grow with 15.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y15.99%

0

5. Dividend

5.1 Amount

No dividends for BFLY!.
Industry RankSector Rank
Dividend Yield N/A

BUTTERFLY NETWORK INC

NYSE:BFLY (1/14/2025, 8:25:45 PM)

After market: 3.37 0 (0%)

3.37

+0.02 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)N/A N/A
Inst Owners30.67%
Inst Owner Change0%
Ins Owners8.63%
Ins Owner Change6.21%
Market Cap718.01M
Analysts84.44
Price Target3.32 (-1.48%)
Short Float %10.98%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.44%
Min EPS beat(2)9.51%
Max EPS beat(2)31.37%
EPS beat(4)3
Avg EPS beat(4)1.67%
Min EPS beat(4)-52.51%
Max EPS beat(4)31.37%
EPS beat(8)7
Avg EPS beat(8)9.78%
EPS beat(12)10
Avg EPS beat(12)15.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)6.06%
Max Revenue beat(2)7.59%
Revenue beat(4)4
Avg Revenue beat(4)5.54%
Min Revenue beat(4)3.03%
Max Revenue beat(4)7.59%
Revenue beat(8)5
Avg Revenue beat(8)1.51%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.46%
EPS NY rev (1m)0%
EPS NY rev (3m)6.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.42
P/FCF N/A
P/OCF N/A
P/B 3.95
P/tB 4.16
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.36
BVpS0.85
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE -54.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.6%
FCFM N/A
ROA(3y)-30%
ROA(5y)N/A
ROE(3y)-39.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 47.61%
Cap/Sales 6.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.66
Quick Ratio 2.95
Altman-Z 0.7
F-Score3
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)246.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.43%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.46%
EPS Next Y45.6%
EPS Next 2Y21.53%
EPS Next 3Y15.99%
EPS Next 5YN/A
Revenue 1Y (TTM)11.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.33%
Revenue Next Year24.78%
Revenue Next 2Y21.4%
Revenue Next 3Y20.26%
Revenue Next 5YN/A
EBIT growth 1Y29.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.62%
EBIT Next 3Y23.81%
EBIT Next 5YN/A
FCF growth 1Y72.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.76%
OCF growth 3YN/A
OCF growth 5YN/A